Table 3 Mean quality rating* of systematic reviews addressing particular health system topics, by focus and type of systematic review
From: The global stock of research evidence relevant to health systems policymaking
Domains** | All reviews (n = 2,928)†| All LMIC-focused reviews (n = 696)†| All types of systematic reviews†| ||
|---|---|---|---|---|---|
Cochrane systematic reviews of effects (n = 484)†| Systematic reviews of effects (n = 2408)†| (Quantitative) Systematic reviews addressing other types of questions*** (n = 520)†| |||
Governance arrangement (n = 197) | 5.6 | 5.4 | 10.3 | 6.6 | 4.5 |
• Policy authority (n = 46) | 5.1 | 5.4 | 9.9 | 5.7 | 4.5 |
• Organizational authority (n = 69) | 5.5 | 7.0 | 10.3 | 6.6 | 4.7 |
• Commercial authority (n = 33) | 4.6 | 4.1 | 10.5 | 5.4 | 3.6 |
• Professional authority (n = 50) | 5.4 | 4.8 | 10.3 | 6.4 | 4.3 |
• Consumer & stakeholder involvement (n = 60) | 5.7 | 5.3 | 10.3 | 6.5 | 4.7 |
Financial arrangement (n = 219) | 5.9 | 6.6 | 9.9 | 6.4 | 4.4 |
• Financing systems (n = 50) | 5.1 | 5.7 | 10.5 | 6.1 | 3.7 |
• Funding organizations (n = 25) | 4.7 | 5.5 | 9.3 | 5.0 | 3.5 |
• Remunerating providers (n = 97) | 5.5 | 5.8 | 9.4 | 5.6 | 5.4 |
• Purchasing products & services (n = 27) | 4.4 | 4.2 | 10.0 | 4.8 | 3.9 |
• Incentivizing consumers (n = 83) | 7.0 | 7.7 | 10.0 | 7.4 | 4.5 |
Delivery arrangement (n = 2,395) | 6.3 | 6.8 | 9.9 | 6.7 | 4.5 |
• How care is designed to meet consumers' needs (n = 883) | 6.5 | 6.7 | 10.0 | 6.7 | 5.0 |
• By whom care is provided (n = 1,276) | 6.2 | 6.6 | 9.9 | 6.6 | 4.5 |
• Where care is provided (n = 642) | 6.6 | 7.3 | 9.9 | 7.0 | 4.9 |
• With what supports is care provided (n = 807) | 6.1 | 6.8 | 10.0 | 6.4 | 4.5 |
Implementation strategy (n = 1,519) | 6.3 | 6.8 | 9.8 | 6.5 | 4.9 |
• Consumer-targeted strategy (n = 1,118) | 6.5 | 6.9 | 10.0 | 6.7 | 4.9 |
• Provider-targeted strategy (n = 562) | 6.0 | 6.5 | 9.5 | 6.2 | 5.0 |
• Organization-targeted strategy (n = 53) | 5.9 | 6.4 | 9.7 | 6.2 | 5.4 |